Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 30, 2013

Acacia, Flexion, GSK KaloBios, MannKind, Merrimack, RedHill, Spectrum, Theravance

Phase II
Acacia begins CINV trial . . . read more

Flexion posts good OA results . . . read more

Merrimack ovarian cancer treatment falls short . . . read more

Spectrum completes enrollment for melphalan trial . . . read more

Phase III
RedHill starts H.pylori trial . . . read more

Filings
KaloBios gets orphan designation for CF treatment . . . read more

FDA Accepts Afrezza Submission . . . read more

Launches
GSK, Theravance launch Breo Ellipta . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters